Page last updated: 2024-08-22

angiotensin ii and pirarubicin

angiotensin ii has been researched along with pirarubicin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsumura, Y; Mitsuhata, N; Ohmori, H; Seki, M1
Hayashida, S; Hirasawa, T; Mitsui, H; Nasu, T; Shinohara, Y; Uchiyama, K1
Aoki, A; Naito, K; Nakamura, K; Shimabukuro, T; Tei, Y; Uchiyama, K1

Trials

1 trial(s) available for angiotensin ii and pirarubicin

ArticleYear
[The preventive effect of granisetron on digestive tract symptoms induced by arterial infusion of anticancer and hypertensive agents in combination with radiotherapy--a study of forty patients with bladder cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:5

    Topics: Aged; Angiotensin II; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Child; Cisplatin; Doxorubicin; Female; Granisetron; Humans; Infusions, Intra-Arterial; Methylprednisolone; Nausea; Tegafur; Urinary Bladder Neoplasms; Vomiting

1995

Other Studies

2 other study(ies) available for angiotensin ii and pirarubicin

ArticleYear
Intra-arterial infusion chemotherapy in combination with angiotensin II for advanced bladder cancer.
    The Journal of urology, 1986, Volume: 136, Issue:3

    Topics: Adult; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Regional Blood Flow; Urinary Bladder Neoplasms

1986
Angiotensin-II combined intra-arterial chemotherapy for locally advanced bladder cancer: a case series study at a single institution.
    Hinyokika kiyo. Acta urologica Japonica, 2006, Volume: 52, Issue:2

    Topics: Aged; Aged, 80 and over; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Survival Rate; Urinary Bladder Neoplasms

2006